YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Going Long vs Going for the Sale


December 20, 2012 | Do biotechs today have a long term plan or vision? Should they? With Big Pharma seemingly always on the hunt for new technologies and targets to snatch up, do you need a long term plan? Or is an M&A goal good enough? Xconomy
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.